{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:48:51Z","timestamp":1788281331167,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00105-020-04677-1","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T11:03:49Z","timestamp":1598612629000},"page":"752-761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hyperandrogenismus, adrenale Dysfunktion und Hirsutismus","Hyperandrogenism, adrenal dysfunction, and hirsutism"],"prefix":"10.1007","volume":"71","author":[{"given":"E.","family":"Makrantonaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"4677_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz\u00a0R, Carmina\u00a0E, Chen\u00a0Z et\u00a0al (2016) Polycystic ovary syndrome. Nat Rev Dis Primers 2:16057","journal-title":"Nat Rev Dis Primers"},{"key":"4677_CR2","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","volume":"95","author":"R Azziz","year":"2011","unstructured":"Azziz\u00a0R, Dumesic\u00a0DA, Goodarzi\u00a0MO (2011) Polycystic ovary syndrome: an ancient disorder? Fertil Steril 95:1544\u20131548","journal-title":"Fertil Steril"},{"key":"4677_CR3","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1210\/jc.2012-1829","volume":"98","author":"JG Bentzen","year":"2013","unstructured":"Bentzen\u00a0JG, Forman\u00a0JL, Johannsen\u00a0TH et al (2013) Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging. J\u00a0Clin Endocrinol Metab 98:1602\u20131611","journal-title":"J Clin Endocrinol Metab"},{"key":"4677_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","volume":"164","author":"U Blume-Peytavi","year":"2011","unstructured":"Blume-Peytavi\u00a0U, Blumeyer\u00a0A, Tosti\u00a0A, Finner\u00a0A, Marmol\u00a0V, Trakatelli\u00a0M, Reygagne\u00a0P, Messenger\u00a0A, European Consensus Group (2011) S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol 164:5\u201315","journal-title":"Br J Dermatol"},{"key":"4677_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1468-3083.2010.03937.x","volume":"25","author":"W Chen","year":"2011","unstructured":"Chen\u00a0W, Obermayer-Pietsch\u00a0B, Hong\u00a0JB et al (2011) Acne-associated syndromes: models for better understanding of acne pathogenesis. J\u00a0Eur Acad Dermatol Venereol 25:637\u2013646","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4677_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1600-0625.2009.00996.x","volume":"19","author":"W Chen","year":"2010","unstructured":"Chen\u00a0W, Tsai\u00a0SJ, Sheu\u00a0HM et\u00a0al (2010) Testosterone synthesized in cultured human SZ95 sebocytes derives mainly from dehydroepiandrosterone. Exp Dermatol 19:470\u2013472","journal-title":"Exp Dermatol"},{"key":"4677_CR7","first-page":"1174","volume":"151","author":"HL Claahsen-Van Der Grinten","year":"2007","unstructured":"Claahsen-Van Der Grinten\u00a0HL, Hoefsloot\u00a0LH (2007) From gene to disease: adrenogenital syndrome and the CYP21A2 gene. Ned Tijdschr Geneeskd 151:1174\u20131177","journal-title":"Ned Tijdschr Geneeskd"},{"key":"4677_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000347196","volume":"226","author":"MG Da Cunha","year":"2013","unstructured":"Da Cunha\u00a0MG, Fonseca\u00a0FL, Machado\u00a0CD (2013) Androgenic hormone profile of adult women with acne. Dermatology 226:167\u2013171","journal-title":"Dermatology"},{"key":"4677_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","volume":"21","author":"D Deplewski","year":"2000","unstructured":"Deplewski\u00a0D, Rosenfield\u00a0RL (2000) Role of hormones in pilosebaceous unit development. Endocr Rev 21:363\u2013392","journal-title":"Endocr Rev"},{"key":"4677_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1210\/jcem-65-3-499","volume":"65","author":"A Dunaif","year":"1987","unstructured":"Dunaif\u00a0A, Graf\u00a0M, Mandeli\u00a0J et\u00a0al (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia. J\u00a0Clin Endocrinol Metab 65:499\u2013507","journal-title":"J Clin Endocrinol Metab"},{"key":"4677_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/jdv.13455","volume":"30","author":"M Harries","year":"2016","unstructured":"Harries\u00a0M, Tosti\u00a0A, Bergfeld\u00a0W et al (2016) Towards a\u00a0consensus on how to diagnose and quantify female pattern hair loss\u2014The \u2018Female Pattern Hair Loss Severity Index (FPHL-SI). J\u00a0Eur Acad Dermatol Venereol 30:667\u2013676","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4677_CR12","volume-title":"Cushing disease","author":"N Kairys","year":"2020","unstructured":"Kairys\u00a0N, Schwell\u00a0A (2020) Cushing disease. StatPearls, Treasure Island"},{"key":"4677_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jdv.14624","volume":"32","author":"V Kanti","year":"2018","unstructured":"Kanti\u00a0V, Messenger\u00a0A, Dobos\u00a0G et al (2018) Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men\u2014short version. J\u00a0Eur Acad Dermatol Venereol 32:11\u201322","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4677_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","volume":"97","author":"E Ludwig","year":"1977","unstructured":"Ludwig\u00a0E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247\u2013254","journal-title":"Br J Dermatol"},{"key":"4677_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/MED.0b013e32832b71dc","volume":"16","author":"E Makrantonaki","year":"2009","unstructured":"Makrantonaki\u00a0E, Zouboulis\u00a0CC (2009) Androgens and ageing of the skin. Curr Opin Endocrinol Diabetes Obes 16:240\u2013245","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"4677_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2133.2006.07671.x","volume":"156","author":"E Makrantonaki","year":"2007","unstructured":"Makrantonaki\u00a0E, Zouboulis\u00a0CC (2007) Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol 156:428\u2013432","journal-title":"Br J Dermatol"},{"key":"4677_CR17","doi-asserted-by":"publisher","first-page":"15029","DOI":"10.1038\/nrdp.2015.29","volume":"1","author":"S Moradi Tuchayi","year":"2015","unstructured":"Moradi Tuchayi\u00a0S, Makrantonaki\u00a0E, Ganceviciene\u00a0R et\u00a0al (2015) Acne vulgaris. Nat Rev Dis Primers 1:15029","journal-title":"Nat Rev Dis Primers"},{"key":"4677_CR18","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price\u00a0J, Bertagna\u00a0X, Grossman\u00a0AB et al (2006) Cushing\u2019s syndrome. Lancet 367:1605\u20131617","journal-title":"Lancet"},{"key":"4677_CR19","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman\u00a0LK, Biller\u00a0BM, Findling\u00a0JW et\u00a0al (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J\u00a0Clin Endocrinol Metab 93:1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"key":"4677_CR20","first-page":"251","volume":"54","author":"CE Orfanos","year":"2000","unstructured":"Orfanos\u00a0CE, Adler\u00a0YD, Zouboulis\u00a0CC (2000) The SAHA syndrome. Horm Res 54:251\u2013258","journal-title":"Horm Res"},{"key":"4677_CR21","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.beem.2020.101418","volume":"34","author":"C Tatsi","year":"2020","unstructured":"Tatsi\u00a0C, Flippo\u00a0C, Stratakis\u00a0CA (2020) Cushing syndrome: old and new genes. Best Pract Res Clin Endocrinol Metab 34:101418","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4677_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi\u00a0E, Santos\u00a0A, Yaneva\u00a0M et al (2011) The European Registry on Cushing\u2019s syndrome: 2\u2011year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165:383\u2013392","journal-title":"Eur J Endocrinol"},{"key":"4677_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/bjd.14486","volume":"175","author":"EJ Van Zuuren","year":"2016","unstructured":"Van Zuuren\u00a0EJ, Fedorowicz\u00a0Z (2016) Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol 175:45\u201361","journal-title":"Br J Dermatol"},{"key":"4677_CR24","first-page":"2313","volume":"151","author":"EJ Van Zuuren","year":"2007","unstructured":"Van Zuuren\u00a0EJ, Pijl\u00a0H (2007) Hirsutisme. Ned Tijdschr Geneeskd 151:2313\u20132318","journal-title":"Ned Tijdschr Geneeskd"},{"key":"4677_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ando.2010.02.017","volume":"71","author":"C Vigouroux","year":"2010","unstructured":"Vigouroux\u00a0C (2010) What have we learned form monogenic forms of severe insulin resistance associated with PCOS\/HAIRAN? Ann Endocrinol (paris) 71:222\u2013224","journal-title":"Ann Endocrinol (paris)"},{"key":"4677_CR26","first-page":"1295","volume":"123","author":"KE Von Muhlendahl","year":"1998","unstructured":"Von Muhlendahl\u00a0KE (1998) Problems of delayed diagnosis of uncomplicated adrenogenital syndrome. Dtsch Med Wochenschr 123:1295","journal-title":"Dtsch Med Wochenschr"},{"key":"4677_CR27","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12020-012-9701-4","volume":"42","author":"SF Witchel","year":"2012","unstructured":"Witchel\u00a0SF, Recabarren\u00a0SE, Gonzalez\u00a0F et\u00a0al (2012) Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine 42:526\u2013534","journal-title":"Endocrine"},{"key":"4677_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.14310\/horm.2002.11109","volume":"3","author":"CC Zouboulis","year":"2004","unstructured":"Zouboulis\u00a0CC (2004) The human skin as a\u00a0hormone target and an endocrine gland. HJ 3:9\u201326","journal-title":"HJ"},{"key":"4677_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1610-0387.2003.03011.x","volume":"1","author":"CC Zouboulis","year":"2003","unstructured":"Zouboulis\u00a0CC (2003) Treatment of acne with antiandrogens\u2014an evidence-based review. J\u00a0Dtsch Dermatol Ges 1:535\u2013546","journal-title":"J Dtsch Dermatol Ges"},{"issue":"Suppl 4","key":"4677_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-0625.2004.00255.x","volume":"13","author":"CC Zouboulis","year":"2004","unstructured":"Zouboulis\u00a0CC, Degitz\u00a0K (2004) Androgen action on human skin\u2014from basic research to clinical significance. Exp Dermatol 13(Suppl 4):5\u201310","journal-title":"Exp Dermatol"},{"issue":"Suppl 1","key":"4677_CR31","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1111\/j.1610-0387.2009.07171.x","volume":"8","author":"CC Zouboulis","year":"2010","unstructured":"Zouboulis\u00a0CC, Rabe\u00a0T (2010) Hormonal antiandrogens in acne treatment. J\u00a0Dtsch Dermatol Ges 8(Suppl 1):S60\u2013S74","journal-title":"J Dtsch Dermatol Ges"},{"key":"4677_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00105-014-2853-9","volume":"65","author":"CC Zouboulis","year":"2014","unstructured":"Zouboulis\u00a0CC (2014) Acne vulgaris. Hautarzt 65:733\u2013750","journal-title":"Hautarzt"},{"key":"4677_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000067821","volume":"206","author":"CC Zouboulis","year":"2003","unstructured":"Zouboulis\u00a0CC, Piquero-Martin\u00a0J (2003) Update and future of systemic acne treatment. Dermatology 206:37\u201353","journal-title":"Dermatology"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04677-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-020-04677-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04677-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T23:07:08Z","timestamp":1630105628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-020-04677-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4677"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04677-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"28 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.C.\u00a0Zouboulis hat relevante Honorare von Bayer Healthcare als Mitglied von Advisory Boards und von Jenapharm als Vortragender erhalten. E.\u00a0Makrantonaki gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}